In this study, we investigated the relationship between KRASG12C mutation and TOPK expression in NSCLC and found that, KRASG12C mutation induced TOPK expression by activating MAPK/ERK signalling pathway and increasing the activity of transcription factor Elk1 in NSCLC. Here, PBK is linked to non-small cell lung carcinoma.